A practical approach for eliciting expert prior beliefs about cancer survival in phase III randomized trial

Journal of Clinical Epidemiology

Volumn 62, Issue 4, 2009, Pages

  Hiance, Anne ^a   Chevret, Sylvie ^a,b   Lévy, Vincent ^a,b  

^a SAINT LOUIS HOSPITAL   (France)

^b INSERM   (France)

Author keywords

Bayes; Chronic lymphocytic leukemia; Elicitation; Expert opinion; Prior; Randomized trial

Indexed keywords

ALTERNATIVE HYPOTHESIS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BAYES THEOREM; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL RESEARCH; CONTROLLED STUDY; EFFECT SIZE; EXPERT SYSTEM; HEALTH SURVEY; NULL HYPOTHESIS; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZATION;

EID: 60849133005     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2008.04.009     Document Type: Article

References (29)

1. Berry D.A. Bayesian clinical trials. Nat Rev 5 (2006) 27-36
2. Freedman L.S., Spiegelhalter D.J., and Parmar M.K. The what, why and how of Bayesian clinical trials monitoring. Stat Med 13 13-14 (1994) 1371-1383 discussion 1385-1389
3. Spiegelhalter D.J., Myles J.P., Jones D.R., and Abrams K. Bayesian methods in health technology assessment: a review. Health Technol Assess 4 38 (2000) 1-130
4. Parmar M.K.B., Spiegelhalter D.J., and Freedman L.S. The CHART trials: Bayesian design and monitoring in practice. Stat Med 13 (1994) 1297-1312
5. Chaloner K., and Rhame F.S. Quantifying and documenting prior beliefs in clinical trials. Stat Med 20 4 (2001) 581-600
6. Garthwaite P.H., Kadane J.B., and O'Hagan A. Statistical methods for eliciting probability deistributions. J Am Stat Assoc 100 (2005) 680-701
7. O'Hagan A. Eliciting expert beliefs in substantial practical applications. Statistician 47 Part 1 (1998) 21-35
8. Lilford R.J., Thornton J.G., and Braunholtz D. Clinical trials and rare diseases: a way out of a conundrum. BMJ 311 7020 (1995) 1621-1625
9. Rosner G., and Berry D.A. A Bayesian group sequential design for a multiple arm randomized clinical trial. Stat Med 14 4 (1995) 381-394
10. Freedman L.S., and Spiegelhalter D.J. The assessment of subjective opinion and its use in relation to stopping rules for clinical trials. Statistician 32 (1983) 153-160
11. Chaloner K., Freedman L.S., and Spiegelhalter D.J. Graphical elicitation of a prior distribution for a clinical trial. Statistician 42 (1993) 341-353
12. O'Hagan O., Buck C.E., Daneshkhah A., Eiser J.R., Ggarthwaite P.H., Jenkinson D.J., et al. Uncertain judgement. Eliciting experts' probabilities. Statistics in Medicine (2006), John Wiley and Sons Ltd
13. www.sfgm-tc.com/documents/ProtocolerandomisedPhaseIII.pdf
14. Cheson B.D., Bennett J.M., Grever M., Kay N., Keating M.J., O'Brien S., and Rai K.R. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 87 12 (1996) 4990-4997
15. Leporrier M., Chevret S., Cazin B., Boudjerra N., Feugier P., and Desablens B. Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients. Blood 98 8 (2001) 2319-2325
16. Kadane J., and Wolfson L.J. Experiences in elicitation. Statistician 47 1 (1998) 3-19
17. Tan S.B., Chung Y.F.A., Tai B.C., Cheung Y.B., and Machin D. Elicitation of prior distributions for phase III randomized controlled trial of adjuvant therapy with surgery for hepatocellular carcinoma. Control Clin Trials 24 (2003) 110-121
18. Kalbfleish J.D. Nonparametric Bayesian analysis of survival time data. J R Stat Soc Ser B 40 (1978) 214-221
19. Tsiatis A.A. The asymptotic joint distribution of the efficient scores test for the proportional hazards model calculated over time. Biometrika 68 (1981) 311-315
20. Tan S, Chung YFA, Tai B, Cheung Y, Machin D. Can external and subjective information ever be used to reduce the size of randomized controlled trials? Contemporary Clinical trials, 2007.
21. Schoenfeld D. Sample-size formula for the proportional-hazard regression model. Biometrics 39 (1983) 499-503
22. Spiegelhalter D.J., Freedman L.S., and Parmar M.K. Applying Bayesian ideas in drug development and clinical trials. Stat Med 12 15-16 (1993) 1501-1511 discussion 1513-1517
23. Fayers P., Ashby D., and Parmar M. Tutorial in biostatistics. Bayesian data monitoring in clinical trials. Stat Med 16 (1997) 1413-1430
24. Genest C., and Zidek J.V. Combining probability distributions: a critique and an annotated bibliography. Stat Sci 1 1 (1986) 114-135
25. Bernardo J.M. Reference posterior distributions for Bayesian inference. [with discussion]. J R Stat Soc Ser B 41 (1979) 113-147
26. Van Dongen S., Talloen W., and Lens L. High variation in developmental instability under non-normal developmental error: a Bayesian perspective. J Theor Biol 236 (2005) 263-275
27. White I.R., Pocock S.J., and Wang D. Eliciting and using expert opinions about influence of patient characteristics on treatment effects: a Bayesian analysis of the CHARM trials. Stat Med 24 24 (2005) 3805-3821
28. Abrams K., Ashby D., and Errington D. Simple Bayesian analysis in clinical trials: a tutorial. Control Clin Trials 15 5 (1994) 349-359
29. Rovers M.M., van der Wilt G.J., van der Bij S., Straatman H., Ingels K., and Zielhuis G.A. Bayes' theorem: a negative example of a RCT on grommets in children with glue ear. Eur J Epidemiol 20 1 (2005) 23-28